Living-donor lobar lung transplantation

Hiroshi Date, Masaomi Yamane, Shinichi Toyooka, Takahiro Oto, Yoshifumi Sano

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

PURPOSE OF REVIEW: To address the donor shortage issue, living-donor lobar lung transplantations have been performed in some institutions. This paper will review the current status of living-donor lobar lung transplantation. RECENT FINDINGS: Up to 2006, living-donor lobar lung transplantation has been performed in approximately 300 patients worldwide. As only two lobes are transplanted, cystic fibrosis represents the most common indication for living-donor lobar lung transplantation, because patients are usually small in body size. Indications for living-donor lobar lung transplantation have recently been expanded to include paediatric and adult patients with various lung diseases such as idiopathic pulmonary fibrosis and pulmonary arterial hypertension. Survival appears to be similar to or better than International Society for Heart and Lung Transplantation registry data on cadaveric lung transplantation. Living-donor lobar lung transplantation may improve survival after paediatric lung retransplantation. The Vancouver Forum Lung Group proposed the eligibility criteria for living lobar donation. SUMMARY: This procedure can be applied to restrictive, obstructive, infectious, and hypertensive lung diseases for both paediatric and adult patients. As a result of the possible serious complications after donor lobectomy, living-donor lobar lung transplantation should be performed only for very sick patients by a well-prepared programme.

Original languageEnglish
Pages (from-to)469-472
Number of pages4
JournalCurrent Opinion in Organ Transplantation
Volume12
Issue number5
DOIs
Publication statusPublished - Oct 2007

Fingerprint

Lung Transplantation
Living Donors
Pediatrics
Lung Diseases
Tissue Donors
Lung
Idiopathic Pulmonary Fibrosis
Survival
Body Size
Pulmonary Hypertension
Cystic Fibrosis
Registries

Keywords

  • Bronchiolitis obliterans syndrome
  • Cadaveric lung transplantation
  • Idiopathic interstitial pneumonia
  • Living-donor lobar lung transplantation
  • Pulmonary arterial hypertension

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Living-donor lobar lung transplantation. / Date, Hiroshi; Yamane, Masaomi; Toyooka, Shinichi; Oto, Takahiro; Sano, Yoshifumi.

In: Current Opinion in Organ Transplantation, Vol. 12, No. 5, 10.2007, p. 469-472.

Research output: Contribution to journalArticle

@article{e2fa4a90e68f4efdbb7546253d8b7076,
title = "Living-donor lobar lung transplantation",
abstract = "PURPOSE OF REVIEW: To address the donor shortage issue, living-donor lobar lung transplantations have been performed in some institutions. This paper will review the current status of living-donor lobar lung transplantation. RECENT FINDINGS: Up to 2006, living-donor lobar lung transplantation has been performed in approximately 300 patients worldwide. As only two lobes are transplanted, cystic fibrosis represents the most common indication for living-donor lobar lung transplantation, because patients are usually small in body size. Indications for living-donor lobar lung transplantation have recently been expanded to include paediatric and adult patients with various lung diseases such as idiopathic pulmonary fibrosis and pulmonary arterial hypertension. Survival appears to be similar to or better than International Society for Heart and Lung Transplantation registry data on cadaveric lung transplantation. Living-donor lobar lung transplantation may improve survival after paediatric lung retransplantation. The Vancouver Forum Lung Group proposed the eligibility criteria for living lobar donation. SUMMARY: This procedure can be applied to restrictive, obstructive, infectious, and hypertensive lung diseases for both paediatric and adult patients. As a result of the possible serious complications after donor lobectomy, living-donor lobar lung transplantation should be performed only for very sick patients by a well-prepared programme.",
keywords = "Bronchiolitis obliterans syndrome, Cadaveric lung transplantation, Idiopathic interstitial pneumonia, Living-donor lobar lung transplantation, Pulmonary arterial hypertension",
author = "Hiroshi Date and Masaomi Yamane and Shinichi Toyooka and Takahiro Oto and Yoshifumi Sano",
year = "2007",
month = "10",
doi = "10.1097/MOT.0b013e3282ef7bc5",
language = "English",
volume = "12",
pages = "469--472",
journal = "Current Opinion in Organ Transplantation",
issn = "1087-2418",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Living-donor lobar lung transplantation

AU - Date, Hiroshi

AU - Yamane, Masaomi

AU - Toyooka, Shinichi

AU - Oto, Takahiro

AU - Sano, Yoshifumi

PY - 2007/10

Y1 - 2007/10

N2 - PURPOSE OF REVIEW: To address the donor shortage issue, living-donor lobar lung transplantations have been performed in some institutions. This paper will review the current status of living-donor lobar lung transplantation. RECENT FINDINGS: Up to 2006, living-donor lobar lung transplantation has been performed in approximately 300 patients worldwide. As only two lobes are transplanted, cystic fibrosis represents the most common indication for living-donor lobar lung transplantation, because patients are usually small in body size. Indications for living-donor lobar lung transplantation have recently been expanded to include paediatric and adult patients with various lung diseases such as idiopathic pulmonary fibrosis and pulmonary arterial hypertension. Survival appears to be similar to or better than International Society for Heart and Lung Transplantation registry data on cadaveric lung transplantation. Living-donor lobar lung transplantation may improve survival after paediatric lung retransplantation. The Vancouver Forum Lung Group proposed the eligibility criteria for living lobar donation. SUMMARY: This procedure can be applied to restrictive, obstructive, infectious, and hypertensive lung diseases for both paediatric and adult patients. As a result of the possible serious complications after donor lobectomy, living-donor lobar lung transplantation should be performed only for very sick patients by a well-prepared programme.

AB - PURPOSE OF REVIEW: To address the donor shortage issue, living-donor lobar lung transplantations have been performed in some institutions. This paper will review the current status of living-donor lobar lung transplantation. RECENT FINDINGS: Up to 2006, living-donor lobar lung transplantation has been performed in approximately 300 patients worldwide. As only two lobes are transplanted, cystic fibrosis represents the most common indication for living-donor lobar lung transplantation, because patients are usually small in body size. Indications for living-donor lobar lung transplantation have recently been expanded to include paediatric and adult patients with various lung diseases such as idiopathic pulmonary fibrosis and pulmonary arterial hypertension. Survival appears to be similar to or better than International Society for Heart and Lung Transplantation registry data on cadaveric lung transplantation. Living-donor lobar lung transplantation may improve survival after paediatric lung retransplantation. The Vancouver Forum Lung Group proposed the eligibility criteria for living lobar donation. SUMMARY: This procedure can be applied to restrictive, obstructive, infectious, and hypertensive lung diseases for both paediatric and adult patients. As a result of the possible serious complications after donor lobectomy, living-donor lobar lung transplantation should be performed only for very sick patients by a well-prepared programme.

KW - Bronchiolitis obliterans syndrome

KW - Cadaveric lung transplantation

KW - Idiopathic interstitial pneumonia

KW - Living-donor lobar lung transplantation

KW - Pulmonary arterial hypertension

UR - http://www.scopus.com/inward/record.url?scp=34648858618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34648858618&partnerID=8YFLogxK

U2 - 10.1097/MOT.0b013e3282ef7bc5

DO - 10.1097/MOT.0b013e3282ef7bc5

M3 - Article

AN - SCOPUS:34648858618

VL - 12

SP - 469

EP - 472

JO - Current Opinion in Organ Transplantation

JF - Current Opinion in Organ Transplantation

SN - 1087-2418

IS - 5

ER -